Advanced Biotechnology Incubator (SUNY Downstate)

450 Clarkson Ave., Box 5,

Brooklyn, NY 11203-209

718-270-1011

research.downstate.edu/incubator.htm

Abstract Description

Management

Keywords

Comment | Printable Version | 1 of 1 | |

network/, Development/, Incubator

Description

Downstate's Biotechnology initiative is a comprehensive plan to nurture biotechnology research and development in Brooklyn.

Program/Products/Services

Incubator Facilities Piping, ductwork and other requirements for gas, vacuum and fume hoods Equipment room (autoclave, low-speed centrifuge, glass washer, ice machine, etc. Emergency generator Conference room Wired for high speed data/telecommunications Parking Incubator Floor Plans First Floor Second Floor Third Floor Access to Downstate Medical Center Resources Basic and clinical scientists Medical and scientific library Graduate and MD/PhD students Clinical trials Seminars Conference rooms Animal facilities Specialized research facilities and equipment (e.g., Confocal Microscopy Facility, DNA Sequencing Facility, Electron Microscopy Facility, Gene Chip Instrument System, Kodak Image Station, Protein Structure Laboratory, Transgenic Mouse Core Facility, Video Imaging System) Radioactive material acquisition and disposal Amenities Cafeteria Gym, swimming pool and other exercise facilities Discount theater tickets

Customers/Clients

BioCangen Inc. is a biotechnology company that focuses on developing and commercializing technologies for early cancer detection and prediction of cancer chemosensitivity. BioCangen has developed an Ultra-Sensitive Gene Methylation Amplification Technology (USGMAT) for the detection of early cancer. The USGMAT kit is currently in clinical trials. In addition, BioCangen is establishing an epigenetics-based assay specifically for measuring cancer chemosensitivity. This assay can be potentially applied to prediction of individualized chemotherapy response in several types of cancer including colon, lung, breast and ovarian cancer. BioMolecular, Inc. is a leading technology, product and service provider for the life science community. The company has developed a variety of biological research reagents, such as ultra-speed clone vector, ultra-sensitive PCR system, one step Western blot and magic protein sample solution. These reagents are widely used in molecular biological research, drug discovery and clinical diagnosis. The companys research services include customer gene expression, DNA and RNA purification, gDNA and cDNA library construction, PCR and gene clone, RT-PCR, clinical assay, primer and gene synthesis, DNA sequencing and contracting research project. Biosignal Group was founded by SUNY neuroscientist Dr. Andre Fenton to commercialize neuroscience discoveries and sell them to the neuroscience research and clinical markets. BSG has developed a patent-applied digital signal telemeter (DT), which captures and transmits broadband bioelectric signals wirelessly by radio to a receiver device for analysis and storage in a computer. The DT is an innovative, miniature, battery-operated, portable unit. The company also sells a proprietary video-based tracking system for behavioral research.

2012-02-05-773 SELECT * FROM `master` WHERE CompanyID='11110' AND `Profile_Type` LIKE 'resource' AND `Approved` LIKE 'YES' ORDER BY `Member_Priority` ASC LIMIT 0 , 30